Welcome to Sentrian

Sentrian, the first Remote Patient Intelligence Company, aspires to eliminate all preventable hospitalization by leveraging the revolution in biosensors and clinician-directed machine learning to remotely detect patient deterioration earlier and with higher accuracy.

The Trillion-Dollar Problem

The U.S. is facing an economic crisis because of the increasing prevalence and cost of chronic disease. But the burden of chronic disease is not only financial; it also adversely affects the lives of tens of millions of patients and their families.

» Learn more

Managing Patients with Complex Chronic Disease is Difficult

Improving the lives of such patients is challenging because many of them have multiple chronic diseases and because care teams often don’t have the timely information they need to detect that early signs of exacerbation when it would be possible reverse the process with a relatively modest intervention.

» Learn more

No Time to Waste

The Sentrian Remote Patient Intelligence platform addresses the challenge of managing patients with complex chronic disease, by bridging the gap between patients and clinicians when the patient is home and away from their care team.

» Learn more


Sentrian CEO Dean Sawyer Selected for Prestigious 12 Leaders Program

Sentrian™, the first Remote Patient Intelligence ™ company, today announced that company Co-Founder and CEO Dean Sawyer has been selected as one of 12 visionary entrepreneurs to participate in the prestigious 12 Leaders® program. The one-year program brings together 12 handpicked entrepreneurs, leaders and influencers to learn strategies for maximizing professional growth and entrepreneurial excellence.


Anthem Blue Cross Picks Sentrian’s Remote Intelligence Platform

Sentrian will provide an integrated remote patient monitoring and analytics service to CareMore health plan members with complex chronic diseases. The Sentrian RPI platform is designed to prevent avoidable hospitalization by leveraging the revolution in remote biosensors and machine learning to remotely detect deterioration in patients’ health before it becomes acute.


Donald Jones Joins Sentrian Board

Donald Jones, a globally recognized leader in digital medicine, has joined the Board of Directors for the company. Jones is the CEO of Trial Fusion, a company focused on clinical validation and commercializing digital health products and services and is the Chief Digital Officer of the Scripps Translational Science Institute, where he works with the renowned Eric Topol, MD on the convergence of genomics and wireless health.



Want to learn more on Sentrian’s Remote Patient Intelligence ​and find out its predictive platform enables the building of personalized profiles – next generations analytic modeling in healthcare.